Hvsen Biotech
Latest round
- Series D
Last raised
- Dec 2018
Total raised
- $19M
Investors
- 3
About Hvsen Biotech
, Ltd. has developed into a key enterprise within China’s animal health industry. The company integrates R&D, manufacturing, and sales across its veterinary pharmaceutical operations. The company has expanded its operations with facilities in Wuchang, Dongxihu and Baiquan districts. The company's core products include veterinary drug formulations, active pharmaceutical ingredients, and traditional Chinese veterinary medicine extracts used for disease prevention and treatment in livestock and companion animals. The company generates revenue primarily through the domestic and international sale of veterinary pharmaceuticals and related products.
Who invested in Hvsen Biotech
3 investors across 3 rounds
See all investors in Hvsen Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hvsen Biotech
Who invested in Hvsen Biotech?
Hvsen Biotech has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hvsen Biotech raised?
Hvsen Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Hvsen Biotech last raise money?
Hvsen Biotech's most recent round on record is a Series D, in Dec 2018.
What does Hvsen Biotech do?
Hvsen Biotech is a agribusiness company.
Where is Hvsen Biotech headquartered?
Hvsen Biotech is headquartered in Wuhan, China.
Which VCs invest in companies like Hvsen Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back agribusiness companies at Hvsen Biotech's stage. Their profiles are linked below.
VCs backing agribusiness startups at Series D
Raising like Hvsen Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.